Evidence map›Paper›PMID 36233600›Full record

ArticleJournal of clinical medicine2022

Left Ventricular Diastolic Indices and Their Impact on Outcomes in Patients with Recently Diagnosed Atrial Fibrillation.

Nobuhiro Ikemura, Koki Nakanishi, John A Spertus, Carolyn S P Lam, Takehiro Kimura, Yoshinori Katsumata, Taishi Fujisawa, Ikuko Ueda, Takahiro Ohki, Keiichi Fukuda and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nobuhiro IkemuraDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0002-6347-4460
Koki NakanishiDepartment of Cardiovascular Medicine, The University of Tokyo, Tokyo 113-8654, Japan.
John A SpertusKansas City Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MO 64111, USA.ORCID 0000-0002-2839-2611
Carolyn S P LamDepartment of Cardiology, National Heart Center Singapore, Singapore 169609, Singapore.
Takehiro KimuraDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0003-3532-856X
Yoshinori KatsumataDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Taishi FujisawaDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Ikuko UedaDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Takahiro OhkiDepartment of Cardiology, Tokyo Dental College Ichikawa General Hospital, Ichikawa 272-8513, Japan.
Keiichi FukudaDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Seiji TakatsukiDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Shun KohsakaDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0003-3779-2972

Funding

Japan Society for the Promotion of Science 20H03915Japan Society for the Promotion of Science 20J01755Japan Society for the Promotion of Science 21K16069
6 · The paper itself

Abstract

Background: Early identification of atrial fibrillation (AF) patients at risk for heart failure (HF) remains critical for improving their outcomes. We aimed to investigate whether indices of left ventricular diastolic dysfunction (LVDD) can stratify AF patients without clinical history of HF. Methods: We extracted 1775 patients’ data from a prospective cohort that consecutively recruited recently recognized AF patients with ejection fraction ≥50%. We categorized patients as LVDD grade 0 (none) to 3 (severe) based on mitral deceleration time and E/e’ per the American Society of Echocardiography recommendation. The primary outcome was a composite of all-cause death, stroke, and HF hospitalization during the 2-year follow-up. We also investigated the Atrial Fibrillation Effects on QualiTy-of-Life (AFEQT) scores. Results: Overall, 857 (48.3%) had mild or higher LVDD. Incidence of primary outcomes increased in parallel with LVDD grading (1.8%, 2.8%, 6.5%, and 8.1% for grades 0−3, respectively, p < 0.001), and the presence of grade 3 LVDD was an independent predictor of the primary outcome (adjusted HR 2.28 (vs. grade 0), 95%CI 1.13−4.60). Furthermore, patients with LVDD had lower AFEQT scores at the enrollment and 1-year follow-up. Conclusions: LVDD indices were associated with adverse clinical outcomes and patients’ perceived health status in a recently diagnosed AF cohort without HF.

Indexed as

atrial fibrillationdiastolic dysfunctionheart failurequality of life

Identifiers

PMID36233600
PMCPMC9571305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.